AEHR — AEHR Test Systems Cashflow Statement
0.000.00%
- $260.80m
- $231.39m
- $66.22m
- 53
- 54
- 13
- 34
Annual cashflow statement for AEHR Test Systems, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.8 | -2.03 | 9.45 | 14.6 | 33.2 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.955 | -1.3 | 1.31 | 2.28 | 3.09 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.561 | 0.316 | -9.56 | -7.28 | -14.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.02 | -2.7 | 1.51 | 10 | 1.76 |
Capital Expenditures | -0.163 | -0.227 | -0.416 | -1.36 | -0.749 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | — | — | — | -17.3 | 18 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -0.163 | -0.227 | -0.416 | -18.7 | 17.3 |
Financing Cash Flow Items | -0.01 | -0.02 | -0.429 | -2.06 | -1.6 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.17 | 1.96 | 25.8 | 7.32 | 0.139 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.005 | -0.851 | 26.9 | -1.36 | 19.1 |